Yong Chen

Dr. Yong Chen


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2022 in Computers in Biology and Medicine
Verified
Journal Article
Open access
YWYing Wang
Ying Wang
YYYuan Yuan
Yuan Yuan
WWWenting Wang
Wenting Wang
YHYing He
Ying He
HZHong Zhong
Hong Zhong
LLLi-Qin Liu
Li-Qin Liu
Qingfeiyin (QFY) is a common Chinese herbal formula for the treatment of acute lung injury (ALI). However, its mechanisms of action are unclear. In this study, we systematically explored the effects and mechanism of action of QFY in ALI using network pharmacology and molecular docking. Active compounds and targets of QFY were obtained from TCMSP and TCMID. ALI-related targets were retrieved from GEO datasets combined with GeneCards, OMIM, and TTD databases. A protein-protein interaction (PPI) network was built to screen the core targets. DAVID was used for GO and KEGG pathway enrichment analyses. The tissue and organ distribution of targets was evaluated. Interactions between potential targets and active compounds were assessed by molecular docking. A molecular dynamics simulation was conducted for the optimal core protein-compound complexes obtained by molecular docking. In total, 128 active compounds and 121 targets of QFY were identified. A topological analysis of the PPI network revealed 13 core targets. GO and KEGG pathway enrichment analyses indicated that the effects of QFY are mediated by genes related to inflammation, apoptosis, and oxidative stress as well as the MAPK and PI3K-Akt signaling pathways. Molecular docking and molecular dynamics simulations revealed good binding ability between the active compounds and screened targets. This study successfully predict the effective components and potential targets and pathways involved in the treatment of ALI for QFY. We provided a novel strategy for future research of molecular mechanisms of QFY in ALI treatment. Moreover, the potential active ingredients provide a reliable source for drug screening for ALI.

1 July 2017 in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
Verified
Journal Article
Closed access
YYYue Yang
Yue Yang
LWLei Wang
Lei Wang
YWYong-jiang Wu
Yong-jiang Wu
XLXuesong Liu
Xuesong Liu
YBYuan Bi
Yuan Bi
YCYong Chen
Yong Chen

23 January 2023 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
HMHui Ma
Hui Ma
WFWeiliang Fu
Weiliang Fu
HYHengyuan Yu
Hengyuan Yu
YXYoudong Xu
Youdong Xu
LXLulu Xiao
Lulu Xiao
TXTengfei Xu
Tengfei Xu

4 March 2011 in Separation and Purification Technology
Verified
Journal Article
Closed access
LWLonghu Wang
Longhu Wang
YMYan-Hong Mei
Yan-Hong Mei
FWFeng Wang
Feng Wang
XLXuesong Liu
Xuesong Liu
YCYong Chen
Yong Chen


17 November 2022 in Frontiers in Pharmacology
Verified
Journal Article
Open access
CSCheng-Yu Shentu
Cheng-Yu Shentu
GYGe Yan
Ge Yan
DXDong-Chen Xu
Dong-Chen Xu
YCYong Chen
Yong Chen
LPLi-Hua Peng
Li-Hua Peng
Osteoarthritis (OA) is one of the most common joint degenerative diseases in the world. At present, the management of OA depends on the lifestyle modification and joint replacement surgery, with the lifespan of prosthesis quite limited yet. Effective drug treatment of OA is essential. However, the current drugs, such as the non-steroidal anti-inflammatory drugs and acetaminophen, as well as glucosamine, chondroitin sulfate, hyaluronic acid, are accompanied by obvious side effects, with the therapeutic efficacy to be enhanced. Recently, novel reagents such as IL-1 antagonists and nerve growth factor inhibitors have entered clinical trials. Moreover, increasing evidence demonstrated that active ingredients of natural plants have great potential for treating OA. Meanwhile, the use of novel drug delivery strategies may overcome the shortcomings of conventional preparations and enhance the bioavailability of drugs, as well as decrease the side effects significantly. This review therefore summarizes the pathological mechanisms, management strategies, and research progress in the drug molecules including the newly identified active ingredient derived from medicinal plants for OA therapy, with the drug delivery technologies also summarized, with the expectation to provide the summary and outlook for developing the next generation of drugs and preparations for OA therapy.